TD Cowen lowers Zscaler stock price target on growth deceleration By Investing.com

TD Cowen cut Zscaler’s price target to $180 from $220 while keeping a Buy rating, citing slower fiscal 2027 growth expectations. The company guided for annual recurring revenue growth and revenue growth of 16% to 17% in fiscal 2027, with the lower multiple reflecting a more muted outlook despite 77% gross margins and AI/large-customer momentum. Shares have already fallen 27% over the past six months, suggesting the revised target may reinforce existing pressure rather than trigger a major new rerating.

Analysis

The market is telling you this is no longer a “beat-and-raise” story but a re-rating problem: as growth normalizes, every incremental slowdown compresses the multiple faster than the business can compound. For a high-margin security platform like ZS, that matters because operating leverage only supports the stock if revenue durability stays above the threshold where investors can still justify premium EV/sales; once forward growth drifts into the mid-teens, multiple expansion becomes much less forgiving.

Second-order, this likely shifts enterprise security budgets toward consolidation winners rather than pure-play high-beta names. If buyers are slowing large strategic rollouts, vendors with broader platform breadth, stronger wallet share, or lower sales friction should absorb share without needing the same headline growth rate. That creates a subtle spread trade inside cybersecurity: less about the category and more about whose go-to-market can sustain expansion with lower customer acquisition intensity.

The key catalyst is not the next quarter but whether management can prove that AI-related demand translates into durable module adoption and larger deal sizes within 2-3 quarters. If that doesn’t show up, the market will keep moving the stock from “growth compounder” to “quality software,” which usually implies another 10-15% de-rating even if fundamentals remain solid. Conversely, a few large-customer wins or evidence that guidance was intentionally conservative could snap the multiple back quickly because positioning is already light after the six-month drawdown.

The contrarian view is that the selloff may be overdone relative to the underlying economics: a business with ~77% gross margin, approaching profitability, and recurring revenue visibility does not need hypergrowth to work. At the current setup, the market may be pricing in a structural deceleration before it has evidence that demand is actually broken. That creates an asymmetric setup where a stabilization in bookings can matter more than a modest guidance beat.

Key Decisions for Investors

• Sell ZS on rallies into the next 2-6 weeks if the stock approaches the low $190s; the near-term upside is capped by multiple compression unless fiscal 2027 demand inflects.
• For investors willing to own the quality, buy ZS only after a post-earnings reset or on confirmation that large-deal conversion is reaccelerating; target a 6-12 month horizon with a 15-20% upside case if the multiple re-rates back toward prior norms.
• Pair trade: long a broader platform cybersecurity winner vs. short ZS over 3-6 months; prefer names with better cross-sell and lower dependence on large incremental ARR surprises, using the pair to isolate slowdown risk rather than sector beta.
• If options liquidity is adequate, buy 3-4 month ZS put spreads to express the risk that guidance skepticism widens; downside is defined and the catalyst window is the next estimate cycle.
• Do not short MS on this tape; the article contains no meaningful read-through, and any short in the ticker would be a pure factor trade rather than a thesis-driven position.